James Donaldson on Mental Health - A Mental Health Lifeline: How Psychedelics Could Offer Millions of Americans Hope

Allen On October 8, 2025, Stanford neuroscientist Nolan Williams—a pioneer of rapid-acting treatments for severe depression— died by suicide at age 42 .

His premature death, and the profound loss it represents, underscores the urgency that drove his work: the need for fast-acting, effective treatment options for individuals experiencing acute mental health crises, particularly those enduring chronic and severe suffering.

For patients who have exhausted evidence-based therapies—including selective serotonin reuptake inhibitors (SSRIs), atypical antipsychotics, and cognitive behavioral interventions—access to experimental treatments should be no less available than it is for individuals with refractory cancer or Parkinson’s disease.

Psychedelic therapies are emerging as promising candidates across a range of psychiatric conditions, 1 including major depressive disorder, treatment-resistant depression, post-traumatic stress disorder, obsessive-compulsive disorder, and substance use disorders.

Several compounds—such as lysergic acid diethylamide (LSD), 3,4 -methylenedioxymethamphetamine (MDMA), and psilocybin—have received Breakthrough Therapy designation from the US Food and Drug Administration (FDA).

This designation is designed to accelerate the development and review of drugs that target serious conditions where preliminary research suggests the drug may demonstrate meaningful improvements over existing therapies on clinically significant endpoint measures.

Psychedelic medicines, particularly offered in the context of psychotherapy, may offer several advantages over existing treatments for mental health.

First, and most notably, therapeutic effects—when present—often occur rapidly.

Across clinical trials, symptom improvement is frequently observed during the first post-dosing assessment.

2-4 By contrast, SSRIs may require weeks or months to produce benefit, and many patients cycle through multiple medications titrations before achieving relief.